Results 21 to 30 of about 11,884 (322)
Biological evaluation of the effect of sugammadex on hemostasis and bleeding [PDF]
Korean Journal of Anesthesiology, 2015 BackgroundNotification of sugammadex has been supplemented with a section on hemostasis, including a longer clotting time in the first minutes following injection, without any documented clinical consequences.
Julien Raft +4 more
doaj +1 more source
Evaluation of the vasorelaxant effect of Sugammadex on the arterial smooth muscle in rats
Medicine Science, 2023 Although NMBAs (Neuro Muscular Blocking Agents) have been used for a long time, postoperative residual curarization is still a significant problem. Nowadays, an agent named Sugammadex is used for the reversal of curarization.
Mustafa Karademir +2 more
doaj +1 more source
The Journal of Critical Care Medicine, 2016 Abstract The purpose of this update is to provide recent knowledge and debates regarding the use of sugammadex in the fields of anesthesia and critical care. The review is not intended to provide a comprehensive description of sugammadex and its clinical use.
Marwan Armaly +4 more
openaire +3 more sources
The Journal of Pediatric Pharmacology and Therapeutics, 2023 The neuromuscular blocking drugs rocuronium and vecuronium are often used during general anesthesia. These drugs temporarily paralyze the patient and thus both facilitate placement of an endotracheal tube and prevent any patient movement during surgery ...
Zameer G. Vaswani +4 more
semanticscholar +1 more source
Sugammadex in the neonatal patient☆ [PDF]
Colombian Journal of Anesthesiology, 2013 Abstract Introduction The inclusion of drugs that effectively reverse the neuromuscular junction blockade enhances the profile of drugs used for relaxation of the neuromuscular junction; better yet if these agents are free from any clinically important adverse effects and amenable to use in neonates.
González Cárdenas, Víctor Hugo +1 more
openaire +3 more sources
Scientific Reports, 2022 Sugammadex has been approved for reversal of neuromuscular blockade by vecuronium and rocuronium in adults undergoing surgery. Although widely used in the operating room, sugammadex has not been investigated in the intensive care unit setting. This study
Răzvan Bologheanu +5 more
doaj +1 more source
Advantages and pitfalls of clinical application of sugammadex [PDF]
Anesthesia and Pain Medicine, 2020 Sugammadex, a modified γ-cyclodextrin, is one of the drugs focused on in the anesthetic field because it provides rapid and complete reversal from neuromuscular blockade (NMB) by encapsulating rocuronium.
Hyung Young Lee, Ki Tae Jung
doaj +1 more source
Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report- [PDF]
Korean Journal of Anesthesiology, 2019 Background Sugammadex is a reversal agent for non-depolarizing neuromuscular blockers and widely used worldwide on account of its rapid and effective reversal from neuromuscular blockade, despite its advantages, multiple cases of sugammadex-induced ...
Gunn Hee Kim +6 more
doaj +1 more source
Anesthesiology, 2020 Background: Five percent of adult patients undergoing noncardiac inpatient surgery experience a major pulmonary complication. The authors hypothesized that the choice of neuromuscular blockade reversal (neostigmine vs.
S. Kheterpal +13 more
semanticscholar +1 more source
Annals of Transplantation, 2023 Background Simultaneous pancreas-kidney transplantation (SPK) is a time-consuming and important surgical procedure, which can provide a physiological mean of achieving normoglycemia and render patients free of dialysis. The potential clinical benefits of
Jiancheng Tang +3 more
semanticscholar +1 more source